Position in HROW
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,459,132
+$8,416,414 QoQ
Shares Held
905,560
+6.3% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 223 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. HROW ranks #19 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in HROW
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,459,132 | 905,560 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $30,042,718 | 852,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $38,469,361 | 785,089 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $37,370,527 | 775,644 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,761,923 | 810,803 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $20,590,501 | 774,079 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,193,172 | 721,108 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $32,493,939 | 722,730 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,015,104 | 718,770 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,181,342 | 693,979 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,521,315 | 671,546 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,860,585 | 616,603 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,360,063 | 544,121 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,661,040 | 267,535 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,602,606 | 244,079 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,804,295 | 232,336 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,688,151 | 231,889 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,566,819 | 229,739 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,985,921 | 229,852 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,089,354 | 229,852 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,027,235 | 218,217 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,534,186 | 375,435 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,359,853 | 344,002 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,859,502 | 332,648 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,709,557 | 328,130 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $711,627 | 186,290 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||